FORWARD FEATURES CALENDAR

Deals & Transactions

Maven co-leads GBP3.4m funding round for Gen inCode

UK private equity manager Maven Capital Partners (Maven) has invested GBP1.5 million in Gen inCode, a genetic testing business specialising in the risk assessment and prediction of cardiovascular disease.  Gen inCode raised in total GBP3.4 million, where Maven invested alongside another institutional investor and existing private shareholders.   Gen inCode has

MidOcean Partners acquires Music Reports

MidOcean Partners, a middle market private equity firm focused on the business services and consumer sectors, has acquired Music Reports, an independent provider of music rights data, administration, and management services, from ABRY Partners and the company’s co-founders, Ronald Gertz and Douglas Brainin. MidOcean’s investment will be used to accelerate Music

GI Partners completes acquisition of Clinical Ink

Private investment firm GI Partners has completed the previously announced acquisition of Clinical Ink, a global clinical trial technology company.Headquartered in Horsham, Pennsylvania, Clinical Ink offers data certainty from source to submission during clinical trials. The company’s Lumenis eSource clinical technology is a suite of solutions for capturing and integrating

kSARIA acquires Compulink Cable Assemblies

kSARIA Corporation (kSARIA), a producer and supplier of mission-critical connectivity solutions for the aerospace and defence end markets and a portfolio company of Behrman Capital, has acquired Compulink Cable Assemblies (Compulink). Financial terms of the transaction have not been disclosed.Headquartered in St Petersburg, Florida, Compulink is an AS9100-registered manufacturer of

Phosplatin Therapeutics completes USD18.4m private financing round

Phosplatin Therapeutics, a clinical stage pharmaceutical company focused on oncology therapeutics, has completed an oversubscribed USD18.4 million private financing round. Participation included new and existing investors, inclusive of family offices from the US, Europe and Asia-Pacific, and high net worth individuals. Robert Fallon, President and Chief Executive Officer of Phosplatin Therapeutics,

Apparis secures USD3m in seed funding

Apparis, a vegan fashion brand best known for its bold and colourful faux fur coats, has closed a USD3 million seed round funding, led by Third Kind Venture Capital.Founded in 2016 and based in New York City, Apparis has quickly grown a cult following for their high quality, high fashion,

Warburg Pincus and Martis Capital merge Qualifacts and Credible Behavioral Health

Warburg Pincus, a global private equity firm focused on growth investing, and Martis Capital, a private equity firm focused exclusively on the healthcare sector, have agreed to merge their respective portfolio companies, Qualifacts and Credible Behavioral Health. The combination of these best-in-class technology companies will elevate the experience of behavioural health

Ara Partners makes majority investment in Path Environmental Technology

Ara Partners, a private equity firm specialising in decarbonisation investments, has made a majority investment in Path Environmental Technology (Path), an industrial services provider headquartered in Houston, Texas. Financial terms of the transaction have not been disclosed.   Path, founded in 2014 and formerly known as Sweat Energy Services, cleans above

NTR completes EUR370m refinance of 220 MW wind portfolio

NTR has successfully completed a EUR370 million portfolio refinance of a 220 MW onshore wind portfolio for its NTR Wind 1 LP fund. The fund was established by NTR to construct and operate onshore wind projects availing of the attractive REFIT (Ireland) and ROC (UK) long-term supports. With all projects in

Events

12 November, 2026 – 5:00 pm

Directory Listings